Contact
Please use this form to send email to PR contact of this press release:
AVM Biotechnology to treat COVID-19 and Influenza ARDS with its “supercharged” version of dexamethasone
TO:
Jena Dalpez
AVM Biotechnology
+1 206-906-9922